Source:http://linkedlifedata.com/resource/pubmed/id/18413313
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2008-6-9
|
pubmed:abstractText |
Mammalian glycan chain elongation is mostly based on extending the type 2 chain, Galbeta1-4GlcNAc, whereas the corresponding type 1 chain, Galbeta1-3GlcNAc, is not normally extended. In a broader context of developing high sensitivity mass spectrometry methodologies for glycomic identification of Le(a) versus Le(x) and linear versus branched poly-N-acetyllactosamine (polyLacNAc), we have now shown that the dimeric type 1 glycan chain, as carried on the lactosylceramides of a human colonic adenocarcinoma cell line, Colo205, not only can be further extended linearly but can likewise be branched at C6 of 3-linked Gal in a manner similar to polyLacNAc. A combination of chemical and enzymatic derivatization coupled with advanced mass spectrometry analyses afforded unambiguous identification of a complex mixture of type 1 and 2 hybrids as well as those fucosylated variants founded exclusively on linear and branched trimeric type 1 chain. We further showed by in vitro enzymatic synthesis that extended type 1 and the hybrid chains can be branched by all three forms of the human I branching enzymes (IGnT) currently identified but with lower efficiency and stringency with respect to branching site preference. Importantly, it was found that a better substrate is one that carries a Gal site for branching that is extended at the non-reducing end by a type 2 and not a type 1 unit, whereas the IGnTs are less discriminative with respect to whether the targeted Gal site is itself beta3- or beta4-linked to GlcNAc at the reducing end.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fucose,
http://linkedlifedata.com/resource/pubmed/chemical/Lactosylceramides,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/poly-N-acetyllactosamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16455-68
|
pubmed:meshHeading |
pubmed-meshheading:18413313-Adenocarcinoma,
pubmed-meshheading:18413313-Cell Line, Tumor,
pubmed-meshheading:18413313-Colonic Neoplasms,
pubmed-meshheading:18413313-Dimerization,
pubmed-meshheading:18413313-Exons,
pubmed-meshheading:18413313-Fucose,
pubmed-meshheading:18413313-Humans,
pubmed-meshheading:18413313-Lactosylceramides,
pubmed-meshheading:18413313-Mass Spectrometry,
pubmed-meshheading:18413313-Polysaccharides,
pubmed-meshheading:18413313-RNA, Messenger,
pubmed-meshheading:18413313-Spectrometry, Mass, Matrix-Assisted Laser...,
pubmed-meshheading:18413313-Subcellular Fractions,
pubmed-meshheading:18413313-Tandem Mass Spectrometry
|
pubmed:year |
2008
|
pubmed:articleTitle |
Identification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses.
|
pubmed:affiliation |
Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|